Service Provider for Glaucoma Research
Glaucoma is a common eye disease that is usually associated with increased eye pressure caused by various factors and damages the optic nerve, which connects the eye to the brain. For glaucoma, Ace Therapeutics offers a wide range of services to researchers worldwide in basic research, drug development and preclinical studies, providing innovative and high-quality solutions to our clients. Our mission is to be a leader in glaucoma research, providing unique drug development and preclinical research solutions that advance our clients' programs.
What We Offer You
- Basic Research
Glaucoma is a neurodegenerative eye disease that causes retinal damage and visual defects. However, the pathophysiological mechanisms of glaucoma are still unclear, and there is no doubt that there is still a need for exploration and progress in the field of basic scientific research on glaucoma. We focus on glaucoma solutions, including glaucoma genetics, genomics, proteomics, metabolomics, biomechanics and other directions. We use advanced histological technologies to conduct all aspects of basic research, which can be applied to the exploration of molecular mechanisms of glaucoma pathology, the discovery of diagnostic biomarkers, and the development of new targets for treatment.
- Drug Development
Glaucoma affects tens of millions of people worldwide, but there are no drugs or treatments that can completely cure it. Pharmacological treatments for glaucoma aim to reduce IOP to slow disease progression and delay visual field loss, with common drugs such as prostaglandin analogs, and existing drugs still falling short. Ace Therapeutics aims to collaborate with biotechnology and biopharmaceutical companies that can systematically summarize and apply the latest advances in glaucoma drug development to find new pharmacological options for the treatment of glaucoma in terms of gene therapy, novel small molecule drugs and glaucoma drug delivery.
- Preclinical Research
In addition to basic glaucoma research services, we provide a range of preclinical studies before a drug enters clinical research, including in vivo and in vitro studies. We can construct different types of animal and cellular models of glaucoma, conduct analytical drug studies, pharmacodynamic, pharmacokinetic and toxicological studies. Ace Therapeutics is committed to using our expertise in biotechnology to assist your drug program to enter clinical studies.
Innovative Ocular Solutions
Eye drops are generally the main treatment for glaucoma, but poor compliance often leads to treatment failure, so we need to develop and innovate effective drugs that are safe, biodegradable, well tolerated, and capable of slow release therapy.
Planning - Work with our experts to identify ocular solutions
Preparation - Create your project sheet and complete it on time
Execution - Enjoy our comprehensive research support
Conclusion - Support your research with complete and reliable results
We look forward to working with you and maintaining a long lasting relationship to help make your project a success. If you have any questions for us, please fill out the form information below and send it to us and we will contact you as soon as possible to find what you are looking for.